Go Pro

Shaftesbury Capital (SHC) Competitors

Shaftesbury Capital logo
GBX 140.28 -0.02 (-0.01%)
As of 12:37 PM Eastern

SHC vs. TALK, AMS, SSY, FME, and AGL

Should you buy Shaftesbury Capital stock or one of its competitors? MarketBeat compares Shaftesbury Capital with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shaftesbury Capital include TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Scisys Group (SSY), Future Metals (FME), and ANGLE (AGL). These companies are all part of the "healthcare" industry.

How does Shaftesbury Capital compare to TalkTalk Telecom Group?

TalkTalk Telecom Group (LON:TALK) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

TalkTalk Telecom Group pays an annual dividend of GBX 0.03 per share. Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.6%. TalkTalk Telecom Group pays out 0.2% of its earnings in the form of a dividend. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Shaftesbury Capital has a net margin of 141.28% compared to TalkTalk Telecom Group's net margin of 0.00%. Shaftesbury Capital's return on equity of 8.78% beat TalkTalk Telecom Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TalkTalk Telecom GroupN/A N/A N/A
Shaftesbury Capital 141.28%8.78%1.52%

Shaftesbury Capital has lower revenue, but higher earnings than TalkTalk Telecom Group. TalkTalk Telecom Group is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TalkTalk Telecom Group£1.52B0.00N/A£12.80N/A
Shaftesbury Capital£238.90M10.70£39.54M£18.507.58

In the previous week, Shaftesbury Capital had 2 more articles in the media than TalkTalk Telecom Group. MarketBeat recorded 2 mentions for Shaftesbury Capital and 0 mentions for TalkTalk Telecom Group. Shaftesbury Capital's average media sentiment score of 0.67 beat TalkTalk Telecom Group's score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the news media.

Company Overall Sentiment
TalkTalk Telecom Group Neutral
Shaftesbury Capital Positive

37.6% of Shaftesbury Capital shares are held by institutional investors. 0.7% of Shaftesbury Capital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Shaftesbury Capital has a consensus price target of GBX 185.67, indicating a potential upside of 32.36%. Given Shaftesbury Capital's stronger consensus rating and higher possible upside, analysts plainly believe Shaftesbury Capital is more favorable than TalkTalk Telecom Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TalkTalk Telecom Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

Shaftesbury Capital beats TalkTalk Telecom Group on 13 of the 15 factors compared between the two stocks.

How does Shaftesbury Capital compare to Advanced Medical Solutions Group?

Advanced Medical Solutions Group (LON:AMS) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Advanced Medical Solutions Group currently has a consensus target price of GBX 270.25, suggesting a potential downside of 3.31%. Shaftesbury Capital has a consensus target price of GBX 185.67, suggesting a potential upside of 32.36%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, analysts plainly believe Shaftesbury Capital is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Shaftesbury Capital has higher revenue and earnings than Advanced Medical Solutions Group. Shaftesbury Capital is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£228.94M2.65£11.22M£4.5261.84
Shaftesbury Capital£238.90M10.70£39.54M£18.507.58

In the previous week, Shaftesbury Capital had 2 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for Shaftesbury Capital and 0 mentions for Advanced Medical Solutions Group. Shaftesbury Capital's average media sentiment score of 0.67 beat Advanced Medical Solutions Group's score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the news media.

Company Overall Sentiment
Advanced Medical Solutions Group Neutral
Shaftesbury Capital Positive

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.6%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Shaftesbury Capital is clearly the better dividend stock, given its higher yield and lower payout ratio.

22.9% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 37.6% of Shaftesbury Capital shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by insiders. Comparatively, 0.7% of Shaftesbury Capital shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Advanced Medical Solutions Group has a beta of 0.701, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, Shaftesbury Capital has a beta of 0.957, suggesting that its stock price is 4% less volatile than the broader market.

Shaftesbury Capital has a net margin of 141.28% compared to Advanced Medical Solutions Group's net margin of 4.35%. Shaftesbury Capital's return on equity of 8.78% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group4.35% 3.87% 2.35%
Shaftesbury Capital 141.28%8.78%1.52%

Summary

Shaftesbury Capital beats Advanced Medical Solutions Group on 15 of the 18 factors compared between the two stocks.

How does Shaftesbury Capital compare to Scisys Group?

Shaftesbury Capital (LON:SHC) and Scisys Group (LON:SSY) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Shaftesbury Capital currently has a consensus target price of GBX 185.67, suggesting a potential upside of 32.36%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, equities analysts plainly believe Shaftesbury Capital is more favorable than Scisys Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Scisys Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Shaftesbury Capital has higher revenue and earnings than Scisys Group. Scisys Group is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shaftesbury Capital£238.90M10.70£39.54M£18.507.58
Scisys Group£59.06M0.00N/A£1.40N/A

37.6% of Shaftesbury Capital shares are held by institutional investors. 0.7% of Shaftesbury Capital shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.6%. Scisys Group pays an annual dividend of GBX 0.02 per share. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Scisys Group pays out 1.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Shaftesbury Capital has a net margin of 141.28% compared to Scisys Group's net margin of 0.00%. Shaftesbury Capital's return on equity of 8.78% beat Scisys Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Shaftesbury Capital141.28% 8.78% 1.52%
Scisys Group N/A N/A N/A

In the previous week, Shaftesbury Capital had 2 more articles in the media than Scisys Group. MarketBeat recorded 2 mentions for Shaftesbury Capital and 0 mentions for Scisys Group. Shaftesbury Capital's average media sentiment score of 0.67 beat Scisys Group's score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the media.

Company Overall Sentiment
Shaftesbury Capital Positive
Scisys Group Neutral

Summary

Shaftesbury Capital beats Scisys Group on 13 of the 15 factors compared between the two stocks.

How does Shaftesbury Capital compare to Future Metals?

Shaftesbury Capital (LON:SHC) and Future Metals (LON:FME) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

37.6% of Shaftesbury Capital shares are owned by institutional investors. 0.7% of Shaftesbury Capital shares are owned by insiders. Comparatively, 0.1% of Future Metals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Shaftesbury Capital has higher revenue and earnings than Future Metals. Future Metals is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shaftesbury Capital£238.90M10.70£39.54M£18.507.58
Future Metals£155.84K67.65-£7.83M-£0.40N/A

Shaftesbury Capital has a beta of 0.957, indicating that its stock price is 4% less volatile than the broader market. Comparatively, Future Metals has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

Shaftesbury Capital has a net margin of 141.28% compared to Future Metals' net margin of -1,051.73%. Shaftesbury Capital's return on equity of 8.78% beat Future Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Shaftesbury Capital141.28% 8.78% 1.52%
Future Metals -1,051.73%-11.89%-11.36%

Shaftesbury Capital currently has a consensus price target of GBX 185.67, indicating a potential upside of 32.36%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, equities research analysts clearly believe Shaftesbury Capital is more favorable than Future Metals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Future Metals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Shaftesbury Capital had 1 more articles in the media than Future Metals. MarketBeat recorded 2 mentions for Shaftesbury Capital and 1 mentions for Future Metals. Shaftesbury Capital's average media sentiment score of 0.67 beat Future Metals' score of 0.00 indicating that Shaftesbury Capital is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shaftesbury Capital
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Future Metals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Shaftesbury Capital beats Future Metals on 14 of the 16 factors compared between the two stocks.

How does Shaftesbury Capital compare to ANGLE?

Shaftesbury Capital (LON:SHC) and ANGLE (LON:AGL) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

Shaftesbury Capital has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shaftesbury Capital£238.90M10.70£39.54M£18.507.58
ANGLE£2.62M2.89-£21.76M-£4.80N/A

Shaftesbury Capital has a beta of 0.957, indicating that its stock price is 4% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, indicating that its stock price is 78% less volatile than the broader market.

Shaftesbury Capital presently has a consensus price target of GBX 185.67, indicating a potential upside of 32.36%. Given Shaftesbury Capital's stronger consensus rating and higher possible upside, analysts plainly believe Shaftesbury Capital is more favorable than ANGLE.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
ANGLE
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

37.6% of Shaftesbury Capital shares are held by institutional investors. Comparatively, 17.5% of ANGLE shares are held by institutional investors. 0.7% of Shaftesbury Capital shares are held by company insiders. Comparatively, 2.7% of ANGLE shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Shaftesbury Capital has a net margin of 141.28% compared to ANGLE's net margin of -1,444.04%. Shaftesbury Capital's return on equity of 8.78% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
Shaftesbury Capital141.28% 8.78% 1.52%
ANGLE -1,444.04%-191.36%-29.89%

In the previous week, Shaftesbury Capital had 2 more articles in the media than ANGLE. MarketBeat recorded 2 mentions for Shaftesbury Capital and 0 mentions for ANGLE. ANGLE's average media sentiment score of 1.38 beat Shaftesbury Capital's score of 0.67 indicating that ANGLE is being referred to more favorably in the news media.

Company Overall Sentiment
Shaftesbury Capital Positive
ANGLE Positive

Summary

Shaftesbury Capital beats ANGLE on 14 of the 16 factors compared between the two stocks.

Get Shaftesbury Capital News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHC vs. The Competition

MetricShaftesbury CapitalREIT IndustryReal Estate SectorLON Exchange
Market Cap£2.56B£3.38B£2.01B£2.84B
Dividend Yield2.85%5.58%7.23%6.17%
P/E Ratio7.585.3329.99368.18
Price / Sales10.70318.40408.9384,612.72
Price / CashN/A113.0568.3627.87
Price / Book0.732.691.387.49
Net Income£39.54M£89.50M-£125.49M£5.89B
7 Day Performance-0.09%0.13%-0.22%-0.48%
1 Month Performance3.69%1.95%-0.13%-1.00%
1 Year Performance-7.34%19.42%-1.24%61.74%

Shaftesbury Capital Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Shaftesbury Capital
4.4487 of 5 stars
GBX 140.28
0.0%
GBX 185.67
+32.4%
-7.3%£2.56B£238.90M7.583,000
TALK
TalkTalk Telecom Group
N/AN/AN/AN/A£1.11B£1.52B7.57500
AMS
Advanced Medical Solutions Group
N/AGBX 279.44
+0.2%
GBX 270.25
-3.3%
+36.2%£607.46M£228.94M61.8210
SSY
Scisys Group
N/AN/AN/AN/A£75.14M£59.06M180.711,376
FME
Future Metals
N/AGBX 1.10
-2.2%
N/A+29.9%£10.54M£155.84KN/A123,200

Related Companies and Tools


This page (LON:SHC) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners